Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Anticoagulation in children.Thromb Res. 2012; 130: 142-146
- Anticoagulation in neonates and children: pitfalls and dilemmas.Blood Rev. 2010; 24: 151-162
International summary, extracorporeal life support organization registry report. 2013. Available at: elsonet.org. Accessed January 20, 2014.
- Extracorporeal life support organization registry report 2012.ASAIO J. 2013; 59: 202-210
- A cell-based model of hemostasis.Thromb Haemost. 2001; 85: 965-968
- Mechanisms and attenuation of hemostatic activation during extracorporeal circulation.Ann Thorac Surg. 2001; 72: S1821-S1831
- Coagulation considerations for infants and children undergoing cardiopulmonary bypass.Paediatr Anaesth. 2011; 21: 31-42
- Anticoagulation and coagulation management for ECMO.Semin Cardiothorac Vasc Anesth. 2009; 13: 154-175
- Thrombin during cardiopulmonary bypass.Ann Thorac Surg. 2006; 82: 2315-2322
- Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.J Thorac Cardiovasc Surg. 1993; 106: 978-987
- Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment.Perfusion. 2008; 23: 173-178
- The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation.ASAIO J. 1999; 45: 250-263
- Tissue factor activity and function in blood coagulation.Thromb Res. 2008; 122: S42-S46
- Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass.J Thorac Cardiovasc Surg. 2002; 123: 951-958
- Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1.Shock. 2013; 40: 195-202
- Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw.J Trauma. 2010; 69: S55-S63
- Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock.Anesth Analg. 2011; 112: 1289-1295
- The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates.Crit Care Med. 2000; 28: 2584-2590
- Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.Thromb Haemost. 2008; 99: 609-615
- Thrombin-induced down-regulation of the platelet membrane glycoprotein Ib-XI complex.Semin Thromb Hemost. 1992; 18: 18-27
- Platelet inhibition is associated with severe bleeding and mortality in children on ECLS.Crit Care Med. 2013; 41: 760
- Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.J Thorac Cardiovasc Surg. 2005; 129: 782-790
- The effect of milrinone on platelet activation as determined by TEG platelet mapping.Anesth Analg. 2009; 108: 1425-1429
- Recombinant plasminogen activator inhibitor-1 protects platelets against the inhibitory effects of plasmin.Thromb Res. 1993; 71: 61-68
- Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey.Pediatr Crit Care Med. 2013; 14: e77-e84
- Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.Arch Surg. 2000; 135: 1042-1047
- Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.J Thorac Cardiovasc Surg. 1994; 108: 1076-1082
- The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery.J Cardiothorac Vasc Anesth. 1996; 10: 458-463
- A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.Anesth Analg. 2008; 106: 419-425
- Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation.ASAIO J. 2007; 53: 111-114
- Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation.ASAIO J. 2013; 59: 63-68
- Coagulation and anticoagulation in extracorporeal membrane oxygenation.Artif Organs. 1999; 23: 979-983
ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support Extracorporeal Life Support Organization, Version 1.3. Ann Arbor (MI): 2013. p. 13. Anticoagulation. Available at: www.elsonet.org. Accessed January 24, 2014.
- Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dosing on survival.Ann Thorac Surg. 2007; 83: 912-919
- Monitoring unfractioned heparin therapy: which anti-factor Xa assay is appropriate?.Thromb Res. 2007; 120: 347-351
- Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin.Am J Clin Pathol. 2006; 126: 416-421
- Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.Haemostasis. 1996; 26: 85-89
- Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.Chest. 1995; 108: 258S-275S
- Global hemostasis testing thromboelastography: old technology, new applications.Clin Lab Med. 2009; 29: 391-407
- TEG and ROTEM: technology and clinical application.Am J Hematol. 2014; https://doi.org/10.1002/ajh.23599
- Reference values for kaolin- activated thromboelastography in healthy children.Anesth Analg. 2007; 105: 1610-1613
- Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients.Anesthesiology. 2012; 117: 531-547
- Protocol based on thromboelastograph (TEG) outperforms physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study.Heart Lung Circ. 2009; 18: 277-288
- Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial.J Thorac Cardiovasc Surg. 2010; 140: 1117-1124
- Coagulation management in patients undergoing mechanical circulatory support.Best Pract Res Clin Anaesthesiol. 2012; 26: 179-198
- Antithrombotic strategies in children receiving long-term Berlin Heart EXCOR ventricular assist device therapy.J Heart Lung Transplant. 2013; 32: 569-573
- Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin.J Biol Chem. 1982; 257: 7360-7365
- Age is a determinant factors for measures of concentration and effect in children requiring unfractionated heparin.Thromb Haemost. 2010; 103: 1085-1090
- Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients.Clin Pharmacokinet. 2013; 52: 967-980
- Direct thrombin inhibitors.Thromb Res. 2002; 106: 275-284
- Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.Crit Care. 2011; 15: R275https://doi.org/10.1186/cc10556
- Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.J Cardiothorac Vasc Anesth. 2013; 27: 30-34
- Argatroban anticoagulation in pediatric patients: a literature analysis.J Pediatr Hematol Oncol. 2006; 28: 4-10
- Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban.Pediatr Crit Care Med. 2006; 7: 255-257
- Lepirudin anticoagulation for heparin-induced thrombocytopenia.J Pediatr. 2002; 140: 264-266
- Anticoagulation therapy trends in children supported by ventricular assist devices: a multi-institutional study.ASAIO J. 2014; https://doi.org/10.1097/MAT. 0000000000000037
- Safety and efficacy of danaparoid (Orgaran) use in children.Acta Haematol. 2006; 115: 237-247
- Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII.Anesthesiology. 2004; 100: 443-445
- Argatroban anticoagulation for cardiac surgery with cardiopulmonary bypass in an infant with double outlet right ventricle and a history of heparin-induced thrombocytopenia.Congenit Heart Dis. 2008; 3: 299-302
- Extracorporeal membrane oxygenation with danaparoid sodium after massive pulmonary embolism.Anesth Analg. 2008; 106: 1101-1103
- Argatroban in extracorporeal membrane oxygenation.Artif Organs. 2007; 31: 461-465
- Lepirudin anticoagulation for heparin-induced thrombocytopenia after cardiac surgery in a pediatric patient.Pharmacotherapy. 2006; 26: 709-712
- Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience.ASAIO J. 2006; 52: 513-516
- Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life.ASAIO J. 2014; 60: 57-62
- Antithrombin III administration in neonates with congenital diaphragmatic hernia during the first three days of extracorporeal membrane oxygenation.J Pediatr Surg. 2013; 48: 1837-1842
- Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association.Circulation. 2013; 128: 2622-2703
- Antifibrinolytic agents in current anesthetic practice.Br J Anaesth. 2013; 111: 549-563
- Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the Platelet Inhibition in Children on cLOpidogrel (PICOLO) trial.Circulation. 2008; 117: 553-559
- Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review.J Pediatr Surg. 2003; 38: 1212-1216
- A multicenter trial of ε-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO.J Pediatr Surg. 1998; 33: 1610-1613
- Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.Perfusion. 2014; 29: 163-170
- Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.Pediatr Crit Care Med. 2010; 11: 98-102
- Letter to the Editor.Pediatr Crit Care Med. 2010; 11: 537-538
- Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery.Interact Cardiovasc Thorac Surg. 2012; 15: 690-694
- Prothrombin complex concentrates: an update.Blood Transfuse. 2010; 8: 149-154
- Very high users of platelet transfusions in the neonatal intensive care unit.Transfusion. 2009; 49: 869-872
- Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist device.Intensive Care Med. 2004; 30: 1814-1820
- Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation.Perfusion. 2013; 28: 54-60
- Blood transfusion and the microcirculation.Transfusion. 2011; 51: 2259-2261
- Does the storage duration of blood products affect outcomes in critically ill patients?.Transfusion. 2011; 51: 1644-1650
- Microcirculatory hemodynamics after acute blood loss followed by fresh and banked blood transfusion.Am J Surg. 2005; 190: 456-462
Article info
Publication history
Published online: July 23, 2014
Footnotes
Disclosures: Partially supported by National Institutes of Health (U54 HL112303).
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
